Dihomo-γ-Linolenoyl Ethanolamide
| Code | Size | Price |
|---|
| TAR-T38993-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Dihomo-γ-Linolenoyl Ethanolamide, an endocannabinoid, is a cannabinoid (CB) receptor agonist with K i s of 857 nM and 598 nM for human recombinant CB1 and CB2 receptors , respectively.
CAS:
150314-34-4
Formula:
C22H39NO2
Molecular Weight:
349.559
Purity:
0.98
SMILES:
CCCCCC=C/CC=C/CC=C/CCCCCCC(=O)NCCO
References
C C Felder, et al. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol. 1995 Sep;48(3):443-50.